1976-1983, a critical period in the history of heparin: the discovery of the antithrombin binding site.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Biochimie

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0300-9084(03)00078-6PMID 12765778
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Heparan sulfate: growth control with a restricted sequence menu.

  2001cited by this paper
• 6-O-Sulfotransferase-1 Represents a Critical Enzyme in the Anticoagulant Heparan Sulfate Biosynthetic Pathway*

  2001cited by this paper
• A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry.

  1999cited by this paper
• Expression of Heparan Sulfate d-Glucosaminyl 3-O-Sulfotransferase Isoforms Reveals Novel Substrate Specificities*

  1999cited by this paper
• The Unique Antithrombin III Binding Domain of Heparin: A Lead to New Synthetic Antithrombotics

  1993cited by this paper
• Biosynthesis of heparin. O-sulfation of the antithrombin-binding region.

  1988cited by this paper
• Binding of heparin to antithrombin III: a chemical proof of the critical role played by a 3-sulfated 2-amino-2-deoxy-D-glucose residue.

  1988cited by this paper
• Synthesis of heparin fragments. A chemical synthesis of the pentasaccharide O-(2-deoxy-2-sulfamido-6-O-sulfo-alpha-D-glucopyranosyl)-(1-4 )-O-(beta-D-glucopyranosyluronic acid)-(1-4)-O-(2-deoxy-2-sulfamido-3,6-di-O-sulfo-alpha-D-glu copyranosyl)-(1-4)-O-(2-O-sulfo-alpha-L-idopyranosyluronic acid)-(1

  1986cited by this paper
• Biosynthesis of heparin

  1986cited by this paper
• Synthesis of Heparin Fragments. A Chemical Synthesis of the Pentasaccharide O-(2-Deoxy-2-sulfamido-6-O-sulfo-α-D-glucopyranosyl)-(l->4)-O-(β-glucopyranosyluronic acid)-(1->4)-O-(2-deoxy-2-sulfamido-3,6-di-O- sulfo-α-D-glucopyranosyl)-

  1986cited by this paper
• Total synthesis of a heparin pentasaccharide fragment having high affinity for antithrombin III

  1984cited by this paper
• Evaluation of critical groups required for the binding of heparin to antithrombin.

  1984cited by this paper
• Extension and structural variability of the antithrombin-binding sequence in heparin.

  1984cited by this paper
• Structure-activity relationship in heparin: a synthetic pentasaccharide with high affinity for antithrombin III and eliciting high anti-factor Xa activity.

  1983cited by this paper
• The antithrombin-binding sequence in heparin. Identification of an essential 6-O-sulfate group.

  1983cited by this paper
• Further characterization of the antithrombin-binding sequence in heparin.

  1982cited by this paper
• The structure of heparin oligosaccharide fragments with high anti-(factor Xa) activity containing the minimal antithrombin III-binding sequence. Chemical and 13C nuclear-magnetic-resonance studies.

  1981cited by this paper
• STRUCTURAL STUDIES ON A BIOLOGICALLY ACTIVE HEXASACCHARIDE OBTAINED FROM HEPARIN

  1981cited by this paper
• [Low molecular weight oligosaccharides active in plasma against factor Xa (author's transl)].

  1981cited by this paper
• The antithrombin-binding sequence of heparin. Location of essential N-sulfate groups.

  1981cited by this paper
• The antithrombin-binding sequence of heparin studied by n.m.r. spectroscopy.

  1981cited by this paper
• Evidence for a 3-O-sulfated D-glucosamine residue in the antithrombin-binding sequence of heparin.

  1980cited by this paper
• The molecular size of the antithrombin‐binding sequence in heparin

  1980cited by this paper
• Anti-Xa active heparin oligosaccharides.

  1980cited by this paper
• Correlation between structure and function of heparin.

  1979cited by this paper
• Structure of the antithrombin-binding site in heparin.

  1979cited by this paper
• Structure-function relationships of heparin species.

  1978cited by this paper
• Anticoagulant activity of heparin: Isolation of antithrombin‐binding sites

  1976cited by this paper
• The separation of active and inactive forms of heparin.

  1976cited by this paper
• Anticoagulant activity of heparin: Separation of high‐activity and low‐activity heparin species by affinity chromatography on immobilized antithrombin

  1976cited by this paper
• Anticoagulant properties of heparin fractionated by affinity chromatography on matrix-bound antithrombin iii and by gel filtration.

  1976cited by this paper
• The relationship of molecular weight, and sulfate content and distribution to anticoagulant activity of heparin preparations.

  1974cited by this paper
• Anticoagulant Action of Heparin

  1973cited by this paper
• The purification and mechanism of action of human antithrombin-heparin cofactor.

  1973cited by this paper
• Identification of iduronic acid as the major sulfated uronic acid of heparin.

  1971cited by this paper
• 220 MHz spectra of heparin, chondroitins, and other mucopolysaccharides

  1970cited by this paper
• l-iduronic acid, a major constituent of heparin

  1970cited by this paper
• Highly purified antithrombin 3 with heparin cofactor activity prepared by disc electrophoresis.

  1968cited by this paper
• Quantitative aspects of antithrombin and heparin in plasma.

  1956cited by this paper
• Studies on the Antithrombin and Heparin Co‐factor Activities of a Fraction Adsorbed from Plasma by Aluminum Hydroxide

  1955cited by this paper
• THE INHIBITION OF BLOOD CLOTTING: AN UNIDENTIFIED SUBSTANCE WHICH ACTS IN CONJUNCTION WITH HEPARIN TO PREVENT THE CONVERSION OF PROTHROMBIN INTO THROMBIN

  1939cited by this paper
• THE THROMBOPLASTIC ACTION OF CEPHALIN

  1916cited by this paper

• An Overview of Anticoagulant Drugs Pharmacology, Therapeutic Approaches, Limitations and Perspectives.

  2026cites this paper
• Establishment of a method for measuring the 3-O-sulfated structure in heparan sulfate.

  2025cites this paper
• Heparin: Over 100 Years of Anticoagulation.

  2025cites this paper
• Therapeutic Potential of C1-Inhibitor in Vascular Diseases and Beyond.

  2025cites this paper
• A Novel Chimeric Molecule of Heparanase and Ig-Fc Enables Histochemical and Cytochemical Detection of O-sulfated Heparan Sulfate

  2025cites this paper
• Editorial: Heparan sulfate-binding proteins in health and disease

  2024cites this paper
• Benchmarking Water Models in Molecular Dynamics of Protein–Glycosaminoglycan Complexes

  2024cites this paper
• Differential Solvent DEEP-STD NMR and MD Simulations Enable the Determinants of the Molecular Recognition of Heparin Oligosaccharides by Antithrombin to Be Disentangled

  2024cites this paper
• Inhibition of catechol-O-methyltransferase (COMT) by heparin oligosaccharides with specific structures.

  2024cites this paper
• State-of-the-art chromatographic and mass spectrometric techniques in heparin structural analysis.

  2024cites this paper
• Sweet but Challenging: Tackling the Complexity of GAGs with Engineered Tailor‐Made Biomaterials

  2023cites this paper
• 色谱技术在肝素结构分析中的研究进展

  2023cites this paper
• Factor XI/XIa Inhibitors: A New Approach to Anticoagulation

  2023cites this paper
• Solvent Model Benchmark for Molecular Dynamics of Glycosaminoglycans

  2023cites this paper
• Repulsive Scaling Replica Exchange Molecular Dynamics in Modeling Protein-Glycosaminoglycan Complexes.

  2023cites this paper
• VSIG4 interaction with heparan sulfates inhibits VSIG4–complement binding

  2023cites this paper
• Studying specificity in protein–glycosaminoglycan recognition with umbrella sampling

  2023cites this paper
• Miniaturized affinity chromatography: A powerful technique for the isolation of high affinity GAGs sequences prior to their identification by MALDI-TOF MS.

  2023cites this paper
• Heparin increases the antibiotic efficacy of colistin

  2023cites this paper
• Crosstalk between Circulating Tumor Cells and Plasma Proteins—Impact on Coagulation and Anticoagulation

  2023cites this paper
• Methods for the Production of Recombinant Heparosan, a Critical Heparin Precursor, from Nonpathogenic E. coli Strains.

  2022cites this paper
• Importance of Heparan Sulfate Proteoglycans in Pancreatic Islets and β-Cells

  2022cites this paper
• Heparin mimetics as potential intervention for COVID-19 and their bio-manufacturing

  2022cites this paper
• Explicit solvent repulsive scaling replica exchange molecular dynamics (RS‐REMD) in molecular modeling of protein‐glycosaminoglycan complexes

  2022cites this paper
• Sequencing analysis of heparin reducing terminals with orthogonal chromatographic approaches.

  2022cites this paper
• Modeling glycosaminoglycan-protein complexes.

  2022cites this paper
• Professor Casu’s contribution to cyclodextrins, the remarkable cage-shaped molecules: a review

  2022cites this paper
• Building Block Analysis of ATIII Affinity Fractions of Heparins: Application to the ATIII Binding Capacity of Non-conventional 3-O-Sulfated Sequences

  2022cites this paper
• Analytical challenges of glycosaminoglycans at biological interfaces

  2021cites this paper
• Heparanized chitosans: towards the third generation of chitinous biomaterials.

  2021cites this paper
• State-of-the-art glycosaminoglycan characterization.

  2021cites this paper
• Updates in Anticoagulation Therapy Monitoring

  2021cites this paper
• Silver-assisted gold-catalyzed formal synthesis of the anticoagulant Fondaparinux pentasaccharide

  2021cites this paper
• Diretrizes da Sociedade Brasileira de Cardiologia sobre Angina Instável e Infarto Agudo do Miocárdio sem Supradesnível do Segmento ST – 2021

  2021cites this paper
• Development of effective heparin extraction method from pig by-products and analysis of their bioavailability

  2020cites this paper
• A synthetic heparinoid blocks Tau aggregate cell uptake and amplification

  2020cites this paper
• Professor Casu and Cyclodextrins

  2020cites this paper
• Degeneracy of the antithrombin binding sequence in heparin: 2-O-sulfated Iduronic acid can replace the critical glucuronic acid.

  2020cites this paper
• Preparation and Application of Nanosensor in Safeguarding Heparin Supply Chain

  2020cites this paper
• Evaluation of top-down mass spectrometry and ion-mobility spectroscopy as a means of mapping protein-binding motifs within heparin chains.

  2020cites this paper
• Combinatorial virtual library screening analysis of antithrombin binding oligosaccharide motif generation by heparan sulfate 3-O-Sulfotransferase 1

  2020cites this paper
• Identification of protein recognition elements within heparin chains using enzymatic foot-printing in solution and on-line SEC/MS.

  2020cites this paper
• Sulfated Non-Saccharide Glycosaminoglycan Mimetics as Novel Drug Discovery Platform for Various Pathologies.

  2020cites this paper
• Viscera of fishes as raw material for extraction of glycosaminoglycans of pharmacological interest.

  2019cites this paper
• Timing of Heparin Addition to the Biomolecular Corona Influences the Cellular Uptake of Nanocarriers.

  2019cites this paper
• Analytical Tools for Physicochemical Characterization and Fingerprinting

  2019cites this paper
• Characterization and Quantification of Highly Sulfated Glycosaminoglycan Isomers by Gated-Trapped Ion Mobility Spectrometry Negative Electron Transfer Dissociation MS/MS.

  2019cites this paper
• Development of low molecular weight heparin by H2O2/ascorbic acid with ultrasonic power and its anti-metastasis property.

  2019cites this paper
• Anticoagulant Heparin Mimetics via RAFT Polymerization.

  2019cites this paper
• Nonasaccharide Inhibits Intrinsic Factor Xase Complex by Binding to Factor IXa and Disrupting Factor IXa–Factor VIIIa Interactions

  2019cites this paper
• Specificity of glycosaminoglycan-protein interactions.

  2018cites this paper
• Programmable one-pot synthesis of heparin pentasaccharides enabling access to regiodefined sulfate derivatives† †Electronic supplementary information (ESI) available. See DOI: 10.1039/c8sc01743c

  2018cites this paper
• Cooperative Interactions of Three Hotspot Heparin Binding Residues Are Critical for Allosteric Activation of Antithrombin by Heparin.

  2018cites this paper
• Heparan sulfate dependent cell signaling and associated pathophysiology : Implications in tumorigenesis and embryogenesis

  2018cites this paper
• Isomeric Separation and Recognition of Anionic and Zwitterionic N-glycans from Royal Jelly Glycoproteins*

  2018cites this paper
• Randomized phase III trial of low-molecular-weight heparin enoxaparin in addition to standard treatment in small-cell lung cancer: the RASTEN trial

  2017cites this paper
• Heparin coatings for improving blood compatibility of medical devices☆

  2017cites this paper
• Improved vascularization of porous scaffolds through growth factor delivery from heparinized polyethylene glycol hydrogels.

  2017cites this paper
• New Insights in Thrombin Inhibition Structure–Activity Relationships by Characterization of Octadecasaccharides from Low Molecular Weight Heparin

  2017cites this paper
• Quantitative analysis of antithrombin III binding site in low molecular weight heparins by exhausetive heparinases digestion and capillary electrophoresis.

  2017cites this paper
• Glycosaminoglycans from marine sources as therapeutic agents.

  2017cites this paper
• Molecular size is important for the safety and selective inhibition of intrinsic factor Xase for fucosylated chondroitin sulfate.

  2017cites this paper
• Chemical biology tools for structure-function studies on heparan sulphates : decoding specificity in FGF signalling

  2017cites this paper
• A jasmonic acid derivative improves skin healing and induces changes in proteoglycan expression and glycosaminoglycan structure.

  2017cites this paper
• Comparative Studies on Biochemical and Pharmacological Profiles of Bovine, Ovine and Porcine Heparins

  2017cites this paper
• 2 Heparin and Heparan Sulfate Biosynthesis

  2017cites this paper
• Anticoagulant and antithrombotic activities of modified xylofucan sulfate from the brown alga Punctaria plantaginea.

  2016cites this paper
• Oligosaccharide mapping of heparinase I-treated heparins by hydrophilic interaction liquid chromatography separation and online fluorescence detection and electrospray ionization-mass spectrometry characterization.

  2016cites this paper
• Étude des conséquences de la déficience génétique en ß1,3-galactosyltransférase 6 (ß3GalT6) sur la pathogénie d’une maladie génétique rare, le syndrome d’Ehlers-Danlos (SED)

  2016cites this paper
• Inhibitory serpins. New insights into their folding, polymerization, regulation and clearance.

  2016cites this paper
• homeostasismaintenance,memory and learning, and language communication. Neural circuits in the brain are formed with great precision during embryonic development. Combinatorial actions of transcription factors, growth factors, morphogens, axon guidance molecules, cell adhesion molecules, and recepto

  2016cites this paper
• Structure and biological activity of a fucosylated chondroitin sulfate from the sea cucumber Cucumaria japonica.

  2016cites this paper
• Evaluation d'un variant d'antithrombine dans différentes indications thérapeutiques

  2016cites this paper
• Heparan Sulfate: Biosynthesis, Structure, and Function.

  2016cites this paper
• Pharmacology of Heparin and Related Drugs

  2016cites this paper
• Gas-Phase Analysis of the Complex of Fibroblast GrowthFactor 1 with Heparan Sulfate: A Traveling Wave Ion Mobility Spectrometry (TWIMS) and Molecular Modeling Study

  2016cites this paper
• The US regulatory and pharmacopeia response to the global heparin contamination crisis

  2016cites this paper
• Biochemical characteristics and antioxidant activity of crude and purified sulfated polysaccharides from Gracilaria fisheri

  2016cites this paper
• Proteoglycans and axon guidance: a new relationship between old partners

  2016cites this paper
• Chemical Synthesis of Glycosaminoglycans.

  2016cites this paper
• Are all heparins safe for on-pump heart surgery?

  2016cites this paper
• The “in and out” of glucosamine 6-O-sulfation: the 6th sense of heparan sulfate

  2016cites this paper
• High-resolution probing heparan sulfate-antithrombin interaction on a single endothelial cell surface: single-molecule AFM studies.

  2015cites this paper
• Trends in the development of oral anticoagulants.

  2015cites this paper
• Fragment profiling of low molecular weight heparins using reversed phase ion pair liquid chromatography-electrospray mass spectrometry.

  2015cites this paper
• Analytical and statistical comparability of generic enoxaparins from the US market with the originator product.

  2015cites this paper
• Heparin in malignant glioma: review of preclinical studies and clinical results

  2015cites this paper
• Composition, Sequencing and Ion Mobility Mass Spectrometry of Heparan Sulfate-like Octasaccharide Isomers Differing in Glucuronic and Iduronic Acid Content

  2015cites this paper
• Re-visiting the structure of heparin.

  2015cites this paper
• How strong are Ca2+–heparin and Zn2+–heparin interactions?

  2015cites this paper
• Heparinoid hydrogels for cardiovascular tissue regeneration

  2015cites this paper
• Bone Marrow‐Derived Mesenchymal Stem Cells Have Innate Procoagulant Activity and Cause Microvascular Obstruction Following Intracoronary Delivery: Amelioration by Antithrombin Therapy

  2015cites this paper
• Isolation of a pure octadecasaccharide with antithrombin activity from an ultra-low-molecular-weight heparin.

  2014cites this paper
• Lipid-lowering effect of molluscan (Katelysia opima) glycosaminoglycan (GAG) in hypercholesterolemic induced rats

  2014cites this paper
• Liquid chromatography-diode array detection-mass spectrometry for compositional analysis of low molecular weight heparins.

  2014cites this paper
• Anticoagulant motifs of marine sulfated glycans

  2014cites this paper
• Bottom-Up Low Molecular Weight Heparin Analysis Using Liquid Chromatography-Fourier Transform Mass Spectrometry for Extensive Characterization

  2014cites this paper
• A personal voyage through the proteoglycan field.

  2014cites this paper
• Conformational Activation of Antithrombin by Heparin Involves an Altered Exosite Interaction with Protease*

  2014cites this paper
• Synthesis of the heparin-based anticoagulant drug fondaparinux.

  2014cites this paper